ClinicalTrials.Veeva

Menu

Change in Biting Force After Botox Injection

B

British University In Egypt

Status

Completed

Conditions

Bruxism

Treatments

Drug: Botox Injectable Product

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Implant rehabilitation is a successful treatment option for edentulous patients. Decreasing bone loss around implants is an important target for all implantologists. It has been shown that pathological forces, such as bruxism, may in fact result in bone loss and eventual implant failure.

Botilinium Toxin is a material of many clinical uses. Beside its cosmetic applications, it has been used in the treatment of masseter muscle hypertrophy.

Purpose: To investigate the effect of botilinium toxin injection on biting forces, and its ultimate effect on peri-implant bone changes.

Enrollment

20 patients

Sex

Female

Ages

45 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with a partially edentulous mandible, Kennedy Class I configuration, who are indicated for rehabilitation with partial implant overdenture prostheses, and who complained of Bruxism.

Exclusion criteria

  • The presence of notable facial asymmetry.
  • Severe malocclusion
  • Pregnancy
  • A history of any serious medical illness
  • Drug allergy.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

20 participants in 2 patient groups

Botox
Experimental group
Treatment:
Drug: Botox Injectable Product
Control No Botox
No Intervention group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems